1,467 results on '"Merseburger, Axel S."'
Search Results
2. Proteomic analysis of the urothelial cancer landscape
3. Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network
4. Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells
5. Notfälle (Krankheiten, Verletzungen)
6. Epidemiologie des metastasierten Prostatakarzinoms
7. Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group Multi-institutional Observational Study
8. Medikamentöse Therapie des metastasierten Nierenzellkarzinoms
9. Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations
10. Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials
11. Radiomics vs radiologist in prostate cancer. Results from a systematic review
12. The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic
13. Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study
14. Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
15. Medikamentöse Therapie des metastasierten Nierenzellkarzinoms
16. Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients
17. Validation of diagnostic nomograms based on CE–MS urinary biomarkers to detect clinically significant prostate cancer
18. Systemtherapie des mCRPC
19. Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
20. Therapy Optimization in the Management of Metastatic Hormone-sensitive Prostate Cancer: Insights from the ARASENS Study
21. Large Language Modelle zur schnellen Vereinfachung der Eingabe von Qualitätssicherungsdaten: Performance-Test mit Echtdaten am Beispiel der Tumordokumentation in der Urologie
22. Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study
23. Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis
24. Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer
25. Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals
26. The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control study
27. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes
28. Comprehensive Nomogram for Prediction of the Uric Acid Composition of Ureteral Stones as a Part of Tailored Stone Therapy
29. A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations with Smoking, Alcohol Consumption, and Metabolic Syndrome
30. Metastatic Surgery in Advanced Renal Cell Carcinoma
31. Surgical Methods in Treatment of Kidney Tumors: Open Surgery Versus Laparoscopy Versus Robotic Surgery
32. Partial Versus Total Nephrectomy: Indications, Limitations, and Advantages
33. Prognostic and Predictive Markers, and Stratifications Tables, for the Detection and Treatment of Renal Cell Carcinoma
34. Advisable Follow-Up for Kidney Tumors
35. Treatment of Small Renal Masses
36. Systemic and Sequential Therapy in Advanced Renal Cell Carcinoma
37. Epidemiology of Renal Cell Carcinoma and Its Predisposing Risk Factors
38. Molecular Heterogeneity of Renal Cell Carcinoma
39. Symptoms of Kidney Cancer and Appropriate Diagnostic Tools
40. Histological (Sub)Classifications and Their Prognostic Impact in Renal Cell Carcinoma
41. Clinical Trials and Their Principles in Urologic Oncology
42. Bone Target Therapy in Urologic Malignancies
43. Medikamentöse Therapie des metastasierten Nierenzellkarzinoms
44. Erhaltungstherapie beim Urothelkarzinom
45. Klinik
46. Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma
47. New computed tomographic predictors of complicated perioperative course of 17.5F mini-percutaneous nephrolithotomy (mini-PNL)
48. Hemopatch® as a Hemostatic Agent is Safe in Partial Nephrectomy: A Large, Single-Surgeon Retrospective Evaluation
49. Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World Scenario
50. Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.